Skip to content

OptimizeRx OPRX Net Income

Net Income at other companies

Veeva Systems logo
Veeva SystemsVEEV
$260.94M+14.4%
Phreesia logo
PhreesiaPHR
$2.96M+176%
Doximity logo
DoximityDOCS
$19.11M-69.4%
GoodRx Holdings, Inc. logo
GoodRx Holdings, Inc.GDRX
$1.17M-89.4%
PubMatic logo
PubMaticPUBM
-$12.51M-31.9%
National Research Corporation logo
National Research CorporationNRC
$3.22M+11.1%

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total debt$23.7M-27.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Market cap$107.34M-54.1%
Enterprise value$110.88M-55.0%
P/E15.7×
P/S-1.2×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%
Net margin6.4%+3.6pp
FCF margin13.4%+4.8pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's net income?
OptimizeRx (OPRX) reported net income of -$495K in Q1 2026.
How has OptimizeRx's net income changed year-over-year?
OptimizeRx's net income increased by 77.5% year-over-year, from -$2.2M to -$495K.
What is the long-term trend for OptimizeRx's net income?
Over 4 years (2021 to 2025), OptimizeRx's net income has grown at a 91.9% compound annual growth rate (CAGR), from $378.08K to $5.13M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.